October 20, 2021 Pre-clinical data of ensovibep, a multi-specific DARPin therapeutic with high potency against all frequent SARS-CoV-2 variants September 10, 2021 MP Corporate Presentation August 26, 2021 H1 2021 Results and Corporate Update March 9, 2021 H.C. Wainwright Global Life Sciences Conference March 2, 2021 Cowen 41st Annual Health Care Conference February 25, 2021 Leerink 10th Annual Global Healthcare Conference February 5, 2021 MP FY 2020 presentation and webcast 2:00 pm CET, Molecular Partners HQ, Schlieren January 14, 2021 JP Morgan 39th Annual Virtual Healthcare Conference January 13, 2021 Baader Helvea Swiss Equities Conference December 17, 2020 R&D Day 2020 (Virtual) Pagination Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last »
October 20, 2021 Pre-clinical data of ensovibep, a multi-specific DARPin therapeutic with high potency against all frequent SARS-CoV-2 variants